Discontinued — last reported Q1 '22
Sales Rebates and Discounts
Gilead Sciences Sales Rebates and Discounts increased by 9.5% to $762.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $722.00M to $762.00M. Over 4 years (FY 2020 to FY 2024), Sales Rebates and Discounts shows an upward trend with a 8.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may signal higher competitive pressure or a shift in sales mix toward high-volume, lower-margin channels.
Detailed definition
This represents accrued liabilities for estimated rebates, volume discounts, and chargebacks owed to customers based on...
Peer comparison
Highly relevant for pharmaceutical and medical device companies; peers often disclose this as a significant deduction from gross sales.
sales_rebates_and_discountsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $625.00M | $591.00M | $671.00M | $642.00M | $640.00M | $514.00M | $549.00M | $634.00M | $665.00M | $638.00M | $679.00M | $693.00M | $672.00M | $722.00M | $759.00M | $717.00M | $696.00M | $762.00M |
| QoQ Change | — | -5.4% | +13.5% | -4.3% | -0.3% | -19.7% | +6.8% | +15.5% | +4.9% | -4.1% | +6.4% | +2.1% | -3.0% | +7.4% | +5.1% | -5.5% | -2.9% | +9.5% |
| YoY Change | — | — | — | — | +2.4% | -13.0% | -18.2% | -1.2% | +3.9% | +24.1% | +23.7% | +9.3% | +1.1% | +13.2% | +11.8% | +3.5% | +3.6% | +5.5% |
Sales Rebates and Discounts at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's sales rebates and discounts?
- Gilead Sciences (GILD) reported sales rebates and discounts of $762.00M in Q3 2025.
- How has Gilead Sciences's sales rebates and discounts changed year-over-year?
- Gilead Sciences's sales rebates and discounts increased by 5.5% year-over-year, from $722.00M to $762.00M.
- What is the long-term trend for Gilead Sciences's sales rebates and discounts?
- Over 4 years (2020 to 2024), Gilead Sciences's sales rebates and discounts has grown at a 8.3% compound annual growth rate (CAGR), from $552.00M to $759.00M.
- What does sales rebates and discounts mean?
- Accrued costs for discounts and rebates promised to customers for their purchases.